HighMark Wealth Management’s Celularity CELU Stock Holding History

HighMark Wealth Management’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$263	Hold	441	–	–	﹤0.01%	535
2026 Q1	$586	Hold	441	–	–	﹤0.01%	504
2025 Q4	$489	Hold	441	–	–	﹤0.01%	541
2025 Q3	$913	Hold	441	–	–	﹤0.01%	532
2025 Q2	$864	Hold	441	–	–	﹤0.01%	533
2025 Q1	$763	Hold	441	–	–	﹤0.01%	502
2024 Q4	$917	Hold	441	–	–	﹤0.01%	498
2024 Q3	$1.31K	Hold	441	–	–	﹤0.01%	507
2024 Q2	$1.38K	Hold	441	–	–	﹤0.01%	492
2024 Q1	$2.31K	Sell	441 -1	-0.2%	-$4	﹤0.01%	460
2023 Q4	$1.09K	Sell	442 -330	-43%	-$717	﹤0.01%	504
2023 Q3	$1.71K	Hold	772	–	–	﹤0.01%	471
2023 Q2	$4.11K	Hold	772	–	–	﹤0.01%	383
2023 Q1	$4.78K	Hold	772	–	–	﹤0.01%	405
2022 Q4	$10K	Buy	772 +330	+75%	+$6.08K	0.01%	258
2022 Q3	$10K	Hold	442	–	–	0.01%	238
2022 Q2	$15K	Hold	442	–	–	0.01%	196
2022 Q1	$29K	Buy	+442	New	+$26.5K	0.02%	140

Other funds holding CELU

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

HighMark Wealth Management's CELU Position: Q2 2026 in Review

HighMark Wealth Management held its Celularity (CELU) position steady in Q2 2026 at 441 shares worth $263. The position accounts for ﹤0.01% of the portfolio, ranked #535.

HighMark Wealth Management first reported a position in CELU in Q1 2022 and has held it in 18 quarters since. The position peaked at $29K in Q1 2022. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

HighMark Wealth Management held 441 shares of Celularity worth $263 as of Q2 2026.
HighMark Wealth Management left its Celularity share count unchanged in Q2 2026.
Celularity made up ﹤0.01% of HighMark Wealth Management's portfolio in Q2 2026, its #535 holding.
HighMark Wealth Management first reported a position in Celularity in Q1 2022 and has held it in 18 quarters since.
HighMark Wealth Management's Celularity position peaked at $29K in Q1 2022.
39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.